Systematic Review of the Efficacy and Safety of High-intensity Focussed Ultrasound for Localised Prostate Cancer

Global cancer facts and figures, 2nd edition. American Cancer Society Web site. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf. World Cancer Research Fund International Web site. http://www.wcrf.org. Mambourg F, Jonckheer P, Piérart J, Van Brabandt H. A national clinical practice guideline on the management of localised prostate cancer. KCE report 194C. Belgian Health Care Knowledge Centre Web site. https://kce.fgov.be/sites/default/files/page_documents/KCE_194C_prostate_cancer_0.pdf. Updated 2012. Jonckheer P, Van Landeghem S, Christiaens W, De Winter L, Piérart J, Mertens R. Synthesis: the decisional process for the choice of active surveillance in localized prostate cancer. KCE report 210Cs. Belgian Health Care Knowledge Centre Web site. https://kce.fgov.be/sites/default/files/page_documents/KCE_210Cs_Prostate_cancer_synthesis.pdf. Updated 2013. Prostate cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence Web site. https://www.nice.org.uk/guidance/cg175. Updated 2014. Mottet N, Bellmunt J, Briers E, et al. Guidelines on prostate cancer. European Association of Urology Web site. http://uroweb.org/wp-content/uploads/09-Prostate-Cancer_LR.pdf. Updated 2014. Madersbacher, 2003, High-energy shockwaves and extracorporeal high-intensity focused ultrasound, J Endourol, 17, 667, 10.1089/089277903322518680 High intensity focalized ultrasound for the treatment of localized prostate cancer. Haute Autorité de Santé Web site. http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-12/summary_hifu.pdf. Updated 2010. Obyn, 2009, Assessment of high intensity focused ultrasound for the treatment of prostate cancer, Acta Chir Belg, 109, 581, 10.1080/00015458.2009.11680492 2012, Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow, Prescrire Int, 21, 242 Ahmed, 2008, Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?, World J Urol, 26, 457, 10.1007/s00345-008-0317-5 Cordeiro, 2012, High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer, BJU Int, 110, 1228, 10.1111/j.1464-410X.2012.11262.x Iberti, 2011, A review of focal therapy techniques in prostate cancer: clinical results for high-intensity focused ultrasound and focal cryoablation, Rev Urol, 13, e196 Lukka, 2011, High-intensity focused ultrasound for prostate cancer: a systematic review, Clin Oncol, 23, 117, 10.1016/j.clon.2010.09.002 Ranjan, 2008, High intensity focused ultrasound vs. cryotherapy as primary treatment for prostate cancer, Indian J Urol, 24, 16, 10.4103/0970-1591.38597 Rebillard, 2008, High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology, BJU Int, 101, 1205, 10.1111/j.1464-410X.2008.07504.x Tsakiris, 2008, Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence, J Endourol, 22, 221, 10.1089/end.2007.9849 Uchida, 2009, Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience, Int J Urol, 16, 881, 10.1111/j.1442-2042.2009.02389.x Warmuth, 2010, Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer, Eur Urol, 58, 803, 10.1016/j.eururo.2010.09.009 Wilt, 2008, Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer, Ann Intern Med, 148, 435, 10.7326/0003-4819-148-6-200803180-00209 Yu, 2011, Adverse events of extracorporeal ultrasound-guided high intensity focused ultrasound therapy, PLoS One, 6, e26110, 10.1371/journal.pone.0026110 Ahmed, 2011, Focal salvage therapy compared to whole-gland salvage: a feasibility study, Eur Urol Suppl, 10, 92, 10.1016/S1569-9056(11)60225-X Ahmed, 2012, Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy, Cancer, 118, 4148, 10.1002/cncr.27394 Barret, 2013, Morbidity of focal therapy in the treatment of localized prostate cancer, Eur Urol, 63, 618, 10.1016/j.eururo.2012.11.057 El Fegoun, 2011, Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up, Int Braz J Urol, 37, 213, 10.1590/S1677-55382011000200008 Mishra, 2011, Preliminary safety and efficacy results with robotic high-intensity focused ultrasound: a single center Indian experience, Indian J Urol, 27, 331, 10.4103/0970-1591.85431 Balshem, 2011, GRADE guidelines: 3. Rating the quality of evidence, J Clin Epidemiol, 64, 401, 10.1016/j.jclinepi.2010.07.015 Guyatt, 2013, GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes, J Clin Epidemiol, 66, 151, 10.1016/j.jclinepi.2012.01.006 Lukka, 2010, High-intensity focused ultrasound for prostate cancer: a practice guideline, Can Urol Assoc J, 4, 232, 10.5489/cuaj.870 Focal therapy using high-intensity focused ultrasound for localised prostate cancer. National Institute for Health and Clinical Excellence Web site. http://www.nice.org.uk/guidance/ipg424. Blana, 2008, First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer, Eur Urol, 53, 1194, 10.1016/j.eururo.2007.10.062 Poissonnier, 2007, Control of prostate cancer by transrectal HIFU in 227 patients, Eur Urol, 51, 381, 10.1016/j.eururo.2006.04.012 Mearini, 2009, Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience, J Urol, 181, 105, 10.1016/j.juro.2008.09.024 Muto, 2008, Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer, Jpn J Clin Oncol, 38, 192, 10.1093/jjco/hym173 Uchida, 2005, Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study, Hinyokika Kiyo, 51, 651 Uchida, 2006, Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer, Int J Urol, 13, 228, 10.1111/j.1442-2042.2006.01272.x Blana, 2012, Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry, Prostate Cancer Prostatic Dis, 15, 256, 10.1038/pcan.2012.10 Boutier, 2011, Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer, BJU Int, 108, 1776, 10.1111/j.1464-410X.2011.10251.x Crouzet, 2010, Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients, Eur Urol, 58, 559, 10.1016/j.eururo.2010.06.037 Crouzet, 2011, Oncological outcomes of high-intensity focused ultrasound for localized prostate cancer in 880 consecutive patients, Eur Urol Suppl, 10, 51, 10.1016/S1569-9056(11)60080-8 Crouzet, 2014, Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients, Eur Urol, 65, 907, 10.1016/j.eururo.2013.04.039 Ripert, 2011, Six years’ experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new ‘Stuttgart’ definition for biochemical failure, BJU Int, 107, 1899, 10.1111/j.1464-410X.2010.09710.x Ganzer, 2013, Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer, BJU Int, 112, 322, 10.1111/j.1464-410X.2012.11715.x Netsch, 2010, Development of bladder outlet obstruction after a single treatment of prostate cancer with high-intensity focused ultrasound: experience with 226 patients, J Endourol, 24, 1399, 10.1089/end.2009.0607 Netsch, 2011, Rectourethral fistula after high-intensity focused ultrasound therapy for prostate cancer and its surgical management, Urology, 77, 999, 10.1016/j.urology.2010.10.028 Pfeiffer, 2012, Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes, BJU Int, 110, 1702, 10.1111/j.1464-410X.2012.11375.x Callea, 2010, High-intensity focused ultrasound (HIFU) in prostate cancer: a single centre experience in patients with low, intermediate or high-risk of progression, Arch Ital Urol Androl, 82, 253 Maestroni, 2012, High-intensity focused ultrasound for prostate cancer: long-term followup and complications rate, Adv Urol, 960835 Sung, 2012, Seven years of experience with high-intensity focused ultrasound for prostate cancer: advantages and limitations, Prostate, 72, 1399, 10.1002/pros.22491 Pinthus, 2012, Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology, BJU Int, 110, 1142, 10.1111/j.1464-410X.2012.10945.x Crouzet, 2011, Outcomes of HIFU for localised prostate cancer using the Ablatherm Integrate Imaging® device [in French], Prog Urol, 21, 191, 10.1016/j.purol.2010.07.005 Crouzet, 2010, Reply from authors re: Patrick J. Bastian. High-intensity focused ultrasound for localized prostate cancer: ready for prime time?, Eur Urol, 58, 514, 10.1016/j.eururo.2010.08.008 Crouzet, 2013, HIFU treatment outcomes for localized prostate cancer from the first European centers, J Urol, 189, e613, 10.1016/j.juro.2013.02.2975 Shoji, 2010, Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study, Int J Urol, 17, 715, 10.1111/j.1442-2042.2010.02568.x Inoue, 2011, Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer, Int J Urol, 18, 358, 10.1111/j.1442-2042.2011.02739.x Komura, 2011, Clinically significant urethral stricture and/or subclinical urethral stricture after high-intensity focused ultrasound correlates with disease-free survival in patients with localized prostate cancer, Urol Int, 87, 276, 10.1159/000330909 Elterman, 2011, Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center, Can J Urol, 18, 6037 Komura, 2011, Clinically significant urethral stricture and/or subclinical urethral stricture after high-intensity focused ultrasound (HIFU) paradoxically correlates with disease-free survival in patients with localized prostate cancer, Urol Int, 87, 276, 10.1159/000330909 Rexer, 2014, First-line therapy for “high-risk prostate cancer”. HELP - high intensity focused ultrasound (HIFU) and Eilgard in patients with high-risk prostate cancer - a prospective, randomized study (AP 62/10 of the AUO) [in German], Urologe A, 53, 1063, 10.1007/s00120-014-3515-3 Robertson, 2011, Morbidity of high intensity focused ultrasound (HIFU) as a primary monotherapy for low-risk localized prostate cancer: outcomes from the ENLIGHT trial, Urology, 78, S25, 10.1016/j.urology.2011.07.458 Uchida, 2015, Improved outcomes with advancements in high intensity focused ultrasound devices for the treatment of localized prostate cancer, J Urol, 193, 103, 10.1016/j.juro.2014.07.096 Valerio, 2014, Health technology assessment in evolution - focal therapy in localised prostate cancer, Expert Rev Anticancer Ther, 14, 1359, 10.1586/14737140.2014.932692 Wagner, 2010, Risks in the application of medical devices: human factors in the medical environment, Qual Manag Health Care, 19, 304, 10.1097/QMH.0b013e3181f9ee66 Limani, 2014, Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes, Prostate Cancer, 186782 Ahmed, 2012, Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study, Lancet Oncol, 13, 622, 10.1016/S1470-2045(12)70121-3 Ahmed HU, Dickinson L, Charman S, et al. Focal ablation targeted to the index lesion in multifocal localised prostate cancer: a prospective development study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.030 Azzouzi AR, Barret E, Bennet J, et al. TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer. World J Urol. In press. Valerio, 2014, A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT), Contemp Clin Trials, 39, 57, 10.1016/j.cct.2014.07.006 Tombal B, Desomer A, Jonckheer P, et al. Summary: national practice guideline on the treatment of localised prostate cancer – part 2. KCE report 226Cs. Belgium Health Care Knowledge Centre Web site. http://kce.fgov.be/sites/default/files/page_documents/KCE_226Cs_prostate%20cancer_part2_synthesis.pdf. Updated 2014.